Leo Pharma

LONDON, October 28, 2011 - 'Let's talk about psoriasis - and take action' Results of a recent survey revealing that 50 percent of GP's do not ask patients what impact psoriasis has on their life with 94 percent of them stating it was because they had insufficient time,[1] are worrying according to leading psychologist and prolific academic author, Dr Linda Papadopolous.

COPENHAGEN, Denmark, June 6, 2011 - - NOT INTENDED FOR US MEDIA - Ingenol Mebutate is an Investigational Two-to-Three Day Topical Treatment for Precancerous Skin Disease Clinical data from four Phase 3 studies of ingenol mebutate gel, an investigational treatment for actinic keratosis, were presented publicly for the first time at the 22nd World Congress of Dermatology in Seoul.